
New phase 2 data from a 24-week assessment suggest the first-in-class drug could benefit exercise and pulmonary-vascular outcomes.

New phase 2 data from a 24-week assessment suggest the first-in-class drug could benefit exercise and pulmonary-vascular outcomes.

Increasing OSA severity was associated with increasing markers of obesity.

The supplemental approval for Tyvaso comes on the basis of clinical evidence showing benefit for pulmonary and cardiovascular outcomes in adult patients.

Contrast suppression was substantially lower for patients with major depressive disorder.

A subgroup analysis from DAPA-HF show the SGLT2 inhibitor provided efficacy regardless of HFrEF patient gender.

Individuals with malnutrition had higher mortality rates, as well as higher rates of sepsis and pneumonia.

Investigators conducted what's believed to be the largest prospective observational studies of response to changing treatment regimens in patients with lupus nephritis who do not respond to initial, first-line therapy.

Patients who continued taking semaglutide (Rybelsus/Novo Nordisk) after an initial 20-week therapy period saw continued weight loss, leading to the hope that a new pharmacologic approach to weight loss could be on the horizon.

The new indication for the liposomal-combination therapy is based on safety outcomes from a pair of single-arm trials.

In a 4000 person study, investigators find vaccinated individuals unlikely to transmit COVID-19.

The investigators found lower absolute T-MoCA scores in the NTG arm of the study when compared to the high tension glaucoma cohort.

A budget impact analysis suggest the burgeoning drug class may not be as available as it could be for sickle cell patients.

Joshua Lynch, DO, EMT-P, FAAEM, FACEP, shares ways to improve naloxone accessibility, and Theresa Mallick-Searle, MS, RN-BC, ANP-BC, discusses stigmatization.

Experts weigh in on protocols, policies, and programs that influence patient safety and address when a conversation should ensue with patients about naloxone.

Investigators determined that acid-base disturbances like lactate clearance influenced C diff infection after cardiac surgery.

Overdiagnosis of the infection is driving drug resistance while cases increase. A team of experts consider the value of stewardship in refining care.

A small study found oral vancomycin prophylaxis prevented C diff infection in thoracic transplant patients.

The US has administered more than 143 million COVID-19 vaccinations.

New nationally-representative data show substance-specific use disorders differ in young persons based on when they first experimented.

Multiple myeloma is currently incurable with many patients experiencing relapses.

Researchers compare the NYHA class identifier with KCCQ-QS.

Adults between 18-29 see the largest increase in mental health issues during the pandemic.

An expert offers his perspective on the investigative SLP receptor modulator for atopic dermatitis.

An expert discusses new and emerging therapies for atopic dermatitis.

The investigators did not find psychiatric comorbidities that moderate the association between dementia and suicide attempts.

The Harmony Transcatheter Pulmonary Valve System is designed to treat adult and pediatric patients with pulmonary valve regurgitation.

The role of early aggressive treatment in preventing progression of heart failures and the importance of understanding the root cause of disease.

Javed Butler, MD, MPH, MBA, discusses the staging and difficulties associated with diagnosing heart failure.

The analysis was less statistically powered when comparing sibling discordant.

An expert physician in cardiology and metabolic management walks through a presentation on identifying, addressing, and continually treating for heightened cardiometabolic risk.